Skip to main content
. 2020 Jun 16;8:307. doi: 10.3389/fped.2020.00307

Figure 1.

Figure 1

The presentation of intracellular methotrexate metabolism pathways. Factors that may be responsible for the inconsistency among studies assessing the role of SLC19A1/TS/MTHFR polymorphisms in methotrexate toxicity are marked with an asterisk (*).5,10-mTHF, 5,10-methylenetetrahydrofolate; ABC, ATP-binding cassette; DHFR, dihydrofolate reductase; FPGS, folylpolyglutamate synthase; GGH, γ-glutamyl transferase; miR-595, micro RNA 595; MTHFR, methylenetetrahydrofolate reductase; Mtx, methotrexate; OATP1A/1B, organic anion–transporting polypeptides 1A/1B; p53, p53 protein; SLC19A1, solute carrier family 19 member 1; TS, thymidylate synthase.